Non-hormonal Mgt: Overview & Lifestyle - Setting the Stage
- Indications for Non-hormonal Management:
- Contraindications to Hormone Therapy (HT).
- Patient preference for non-hormonal options.
- Types of Non-hormonal Approaches:
- Comprehensive lifestyle modifications.
- Specific non-hormonal medications (detailed later).
- Key Lifestyle Modifications:
- Diet: Ensure adequate Calcium (1000-1200 mg/day) and Vitamin D (600-800 IU/day).
- Exercise: Regular weight-bearing and aerobic activities.
- Habits: Crucial smoking cessation, alcohol moderation, caffeine reduction.
- Comfort Measures: Layered clothing, maintaining a cool environment.
- Stress Management: Techniques like mindfulness, yoga.
⭐ Lifestyle modifications are the first-line approach for managing mild menopausal symptoms and should be recommended to all symptomatic women.
Non-hormonal Mgt: VMS Pharmacotherapy - Cool & Collected
Pharmacological options for Vasomotor Symptoms (VMS) when hormonal therapy is contraindicated or not preferred:
| Drug Class | Examples (Dose) | MOA | Key Side Effects | Efficacy for VMS |
|---|---|---|---|---|
| SSRIs | Paroxetine (7.5 mg/day FDA-approved; or 10-25 mg/day), Escitalopram (10-20 mg/day), Citalopram (10-20 mg/day) | Serotonin reuptake inhibition | Nausea, dizziness, sexual dysfunction. 📌 SSRI: Sad, Sick, Sexual. | Moderate |
| SNRIs | Venlafaxine XR (37.5-150 mg/day), Desvenlafaxine (50-100 mg/day) | Serotonin & Norepinephrine reuptake inhibition | Nausea, dry mouth, potential ↑BP | Moderate |
| Gabapentinoids | Gabapentin (start 300 mg HS, up to 900-2400 mg/day div. doses), Pregabalin (50-150 mg BID) | Bind to $\alpha2\delta$ subunit of voltage-gated Ca²⁺ channels; modulate neurotransmitter release | Sedation, dizziness, peripheral edema | Moderate |
| Clonidine | $\alpha2$-adrenergic agonist (0.05-0.15 mg/day oral or patch) | Stimulates central $\alpha2$-adrenergic receptors, ↓sympathetic outflow | Dry mouth, hypotension, drowsiness | Limited |
Non-hormonal Mgt: GSM & Other Concerns - Tackling Other Troubles
- Genitourinary Syndrome of Menopause (GSM)/Vulvovaginal Atrophy (VVA)
- Vaginal moisturizers: Regular use (e.g., Replens, Hyalo Gyn) for sustained relief.
- Vaginal lubricants: Coital use (e.g., K-Y Jelly, Astroglide) for symptomatic relief.
⭐ For Genitourinary Syndrome of Menopause (GSM), regular use of vaginal moisturizers provides long-term relief, while lubricants are for symptomatic relief during intercourse.
- Sleep Disturbances
- Sleep hygiene education: Crucial first step.
- If Vasomotor Symptoms (VMS) cause sleep issues, treating VMS helps. Avoid sedatives where possible.
- Mood Symptoms (Anxiety/Depression)
- SSRIs/SNRIs: Effective for VMS, may also improve mood.
- Psychological counseling.
- Complementary & Alternative Medicine (CAM) ⚠️ Discuss with physician.
- Phytoestrogens (e.g., soy isoflavones, red clover): Mechanism involves estrogen receptors; evidence inconsistent.
- Black cohosh: Mechanism unclear; mixed results, potential liver toxicity.
- Acupuncture: Some evidence supporting use for VMS.
High‑Yield Points - ⚡ Biggest Takeaways
- SSRIs/SNRIs (e.g., venlafaxine) are first-line non-hormonal choices for vasomotor symptoms (VMS).
- Gabapentin effectively manages VMS, particularly night sweats.
- Clonidine can reduce VMS; monitor for hypotension and drowsiness.
- Use vaginal moisturizers/lubricants for genitourinary syndrome of menopause (GSM).
- Ospemifene (SERM) treats moderate-severe dyspareunia in GSM.
- Lifestyle changes (e.g., trigger avoidance, cooling) are crucial.
- Emphasize weight-bearing exercise, Calcium/Vitamin D for bone protection.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app
